MarketPulse — Real-Time Financial News & Market Analysis

Latest News

9,547 articles
Sat, Feb 28
GlobeNewswire Inc.GlobeNewswire Inc.··Bragar Eagel & Squire, P.C.

Varonis Stock Collapse Sparks Class Action Lawsuit Over Undisclosed Revenue Shortfall

Class action filed against Varonis Systems for allegedly concealing inability to maintain ARR growth. Stock plunged 48.7% after October earnings revealed 63.9% revenue decline.
VRNSsecurities fraudclass action lawsuit
The Motley FoolThe Motley Fool··Keith Noonan

Oklo's Nuclear Gamble: Can Pre-Revenue Startup Deliver Dividend Riches?

Pre-revenue nuclear startup Oklo surges 97% on AI energy tailwinds but offers no dividends or revenue yet; investors should distinguish long-term technology bets from income strategies.
OKLOXOMBEPBEPHBEPI+2nuclear energydividend income
GlobeNewswire Inc.GlobeNewswire Inc.··Dbv Technologies

DBV Technologies' Peanut Allergy Patch Shows Strong Phase 3 Data Ahead of FDA Submission

DBV Technologies' peanut allergy patch met Phase 3 goals with 46.6% responder rate versus 14.8% placebo, supporting planned 2026 FDA submission.
DBVTFDA approvalBLA submission
GlobeNewswire Inc.GlobeNewswire Inc.··Dbv Technologies

DBV Technologies' Peanut Allergy Patch Shows Strong Phase 3 Data Ahead of FDA Submission

DBV Technologies announced strong Phase 3 data for VIASKIN® Peanut patch, with 82.8% of treated children showing improved tolerance. FDA submission planned for H1 2026.
DBVTFDA approvalclinical trial results
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Pepeto Presale Hits $7.4M as XRP Struggles to Justify $100 Bull Case

Pepeto raises $7.4M in presale with 211% APY staking. XRP down 64% from July peak; analysts project $3-$8 targets by end-2026 amid broad crypto downturn.
XRPCETHVXRPpresale funding
The Motley FoolThe Motley Fool··Steven Porrello

NuScale Stock Rallies From Lows: Can Small Modular Reactors Reach $20?

NuScale stock plunged 77% to $12.85 but analysts see $20+ recovery potential driven by regulatory approval, international deals, and AI-fueled nuclear demand.
SMRBACBACpBBACpEBACpK+12small modular reactorsnuclear energy
The Motley FoolThe Motley Fool··Geoffrey Seiler

Cava Shares Vault 25% on Growth Outlook, but Valuation Raises Caution Flags

Cava shares jumped 25% on Q4 earnings and 2026 guidance forecasting 74-76 new openings, but $22.3M per-location valuation appears stretched.
CAVACMGrestaurant expansiongrowth stock
BenzingaBenzinga··Bibhu Pattnaik

Middle East Aviation Disrupted as Regional Military Tensions Escalate

Middle Eastern air corridors disrupted as major airlines suspend regional flights following US-Iran military escalation.
UALAFLYYgeopolitical tensionsIsrael
GlobeNewswire Inc.GlobeNewswire Inc.··Rosen Law Firm

Inovio Investors Urged to File Claims Before April Deadline in Securities Litigation

Rosen Law Firm notifies Inovio investors of securities class action with April 7, 2026 lead plaintiff deadline, citing alleged false statements on manufacturing and regulatory matters.
INOinvestor lossessecurities class action
The Motley FoolThe Motley Fool··Prosper Junior Bakiny

TransMedics Expands Organ Preservation Technology Amid Fleet Investment

TransMedics expands organ preservation technology platform and invests in dedicated aircraft transportation to improve transplant logistics and organ utilization rates.
TMDXregulatory approvalhealthcare innovation
The Motley FoolThe Motley Fool··Geoffrey Seiler

Meta Secures Major GPU Deal with AMD to Diversify AI Infrastructure

Meta commits to purchasing 6 gigawatts of AMD GPUs and receives warrants for 160 million AMD shares as part of AI infrastructure diversification strategy.
NVDAAMDMETAGOOGGOOGL+1valuationcapital expenditure
The Motley FoolThe Motley Fool··Lawrence Nga

Nu Holdings' Valuation Hinges on Credit Performance During Economic Stress

Nu Holdings' 31x P/E valuation faces pressure as investors gauge credit discipline and asset quality resilience during potential economic stress.
NUemerging marketseconomic downturn
The Motley FoolThe Motley Fool··James Halley

Energy Giants Positioned to Weather Trade Policy Uncertainty

Dominion Energy and Williams Companies offer tariff protection through domestic operations, with strong growth forecasts and consistent dividend histories.
DWMBdata centersdividend growth
The Motley FoolThe Motley Fool··Rick Orford

Palantir Projects 115% U.S. Commercial Growth Amid AI Expansion

Palantir projects 115% U.S. commercial growth, with expanding margins and improved free cash flow generation from AI-driven solutions.
PLTRfree cash flowAI
GlobeNewswire Inc.GlobeNewswire Inc.··Kessler Topaz Meltzer & Check, Llp

Law Firm Probes Mister Car Wash's $7 Take-Private Deal for Potential Breaches

Law firm investigates Mister Car Wash's take-private transaction at $7 per share for potential fiduciary duty violations by board and controlling shareholder.
MCWfiduciary dutysecurities litigation
GlobeNewswire Inc.GlobeNewswire Inc.··Bragar Eagel & Squire, P.C.

Law Firm Opens Investigation Into Driven Brands Over Financial Statement Errors

Law firm investigates Driven Brands over material financial statement errors; stock fell 30% following disclosure.
DRVNclass action lawsuitsecurities investigation
The Motley FoolThe Motley Fool··Josh Kohn-Lindquist

Glenview Capital Establishes $96M DigitalOcean Stake Amid Strong Platform Growth

Glenview Capital establishes $96.45M position in DigitalOcean as the cloud provider reports strong revenue growth and 150% AI service expansion.
AMZNCVSDOCNcloud computingearnings growth
The Motley FoolThe Motley Fool··Keithen Drury

Microsoft Stock Valuation Draws Investor Interest Amid Strong Growth Metrics

Microsoft trades at attractive valuations with 17% revenue growth and 39% Azure expansion, offering potential 25% upside if P/E returns to 30x.
MSFTGOOGGOOGLstock valuationearnings growth
The Motley FoolThe Motley Fool··Matt Dilallo

SCHD ETF Posts 12.9% Annualized Returns Since 2011 Through Dividend Growth Strategy

SCHD ETF achieved 12.9% annualized returns since 2011 by investing in dividend-growth stocks. Top holdings Coca-Cola and PepsiCo exemplify the strategy's success with 50+ year dividend increase records.
KOPEPSCHDdividend stocksdividend growth
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Cogent Biosciences Presents Expanded SUMMIT Trial Results for Bezuclastinib at 2026 AAAAI Meeting

Cogent Biosciences presented expanded SUMMIT trial data showing bezuclastinib achieved significant symptom reduction and tryptase normalization in systemic mastocytosis patients, supporting its FDA regulatory applications.
COGTdisease modificationclinical results